The nexus between RNA-binding proteins and their effectors
RNA-binding proteins (RBPs) regulate essentially every event in the lifetime of an RNA
molecule, from its production to its destruction. Whereas much has been learned about RNA …
molecule, from its production to its destruction. Whereas much has been learned about RNA …
The functions of BET proteins in gene transcription of biology and diseases
KL Cheung, C Kim, MM Zhou - Frontiers in molecular biosciences, 2021 - frontiersin.org
The BET (bromodomain and extra-terminal domain) family proteins, consisting of BRD2,
BRD3, BRD4, and testis-specific BRDT, are widely acknowledged as major transcriptional …
BRD3, BRD4, and testis-specific BRDT, are widely acknowledged as major transcriptional …
DOT1L inhibition reveals a distinct subset of enhancers dependent on H3K79 methylation
L Godfrey, NT Crump, R Thorne, IJ Lau… - Nature …, 2019 - nature.com
Enhancer elements are a key regulatory feature of many important genes. Several general
features including the presence of specific histone modifications are used to demarcate …
features including the presence of specific histone modifications are used to demarcate …
BET inhibition disrupts transcription but retains enhancer-promoter contact
NT Crump, E Ballabio, L Godfrey, R Thorne… - Nature …, 2021 - nature.com
Enhancers are DNA sequences that enable complex temporal and tissue-specific regulation
of genes in higher eukaryotes. Although it is not entirely clear how enhancer-promoter …
of genes in higher eukaryotes. Although it is not entirely clear how enhancer-promoter …
Roles of the BRD4 short isoform in phase separation and active gene transcription
X Han, D Yu, R Gu, Y Jia, Q Wang… - Nature Structural & …, 2020 - nature.com
BRD4, a major tandem-bromodomain-containing transcription regulator, has two isoforms.
The long isoform (BRD4L) has an extended C terminus that binds transcription cofactors …
The long isoform (BRD4L) has an extended C terminus that binds transcription cofactors …
SRPK1/2 and PP1α exert opposite functions by modulating SRSF1-guided MKNK2 alternative splicing in colon adenocarcinoma
Abstract Background The Mnk2 kinase, encoded by MKNK2 gene, plays critical roles in
MAPK signaling and was involved in oncogenesis. Human MKNK2 pre-mRNA can be …
MAPK signaling and was involved in oncogenesis. Human MKNK2 pre-mRNA can be …
MLL-AF4 cooperates with PAF1 and FACT to drive high-density enhancer interactions in leukemia
NT Crump, AL Smith, L Godfrey… - Nature …, 2023 - nature.com
Aberrant enhancer activation is a key mechanism driving oncogene expression in many
cancers. While much is known about the regulation of larger chromosome domains in …
cancers. While much is known about the regulation of larger chromosome domains in …
Serine-arginine protein kinase 1 (SRPK1) promotes EGFR-TKI resistance by enhancing GSK3β Ser9 autophosphorylation independent of its kinase activity in non …
JQ Huang, LX Duan, QY Liu, HF Li, AP Hu, JW Song… - Oncogene, 2023 - nature.com
Resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) is a
major challenge for clinicians and patients with non-small cell lung cancer (NSCLC). Serine …
major challenge for clinicians and patients with non-small cell lung cancer (NSCLC). Serine …
Therapeutic manipulation of IKBKAP mis-splicing with a small molecule to cure familial dysautonomia
Approximately half of genetic disease-associated mutations cause aberrant splicing.
However, a widely applicable therapeutic strategy to splicing diseases is yet to be …
However, a widely applicable therapeutic strategy to splicing diseases is yet to be …
Circular RNAs and RNA splice variants as biomarkers for prognosis and therapeutic response in the liquid biopsies of lung cancer patients
F De Fraipont, S Gazzeri, WC Cho, B Eymin - Frontiers in genetics, 2019 - frontiersin.org
Lung cancer, including non-small cell lung carcinoma (NSCLC), is the most frequently
diagnosed cancer. It is also the leading cause of cancer-related mortality worldwide …
diagnosed cancer. It is also the leading cause of cancer-related mortality worldwide …